pLKO.1-mPRAS40 Citations (2)

Originally described in: Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH Nat Cell Biol. 2007 Mar . 9(3):316-23. PubMed Journal

---

Articles Citing pLKO.1-mPRAS40

Articles
PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling. Yang W, Yang LF, Song ZQ, Shah SZA, Cui YY, Li CS, Zhao HF, Gao HL, Zhou XM, Zhao DM. CNS Neurosci Ther. 2017 May;23(5):416-427. doi: 10.1111/cns.12685. Epub 2017 Mar 14. PubMed
mTOR/miR-142-3p/PRAS40 signaling cascade is critical for tuberous sclerosis complex-associated renal cystogenesis. Zhao S, Hao S, Zhou J, Chen X, Zhang T, Qi Z, Zhang T, Jalal S, Zhai C, Yin L, Bo Y, Teng H, Wang Y, Gao D, Zhang H, Huang L. Cell Mol Biol Lett. 2024 Sep 27;29(1):125. doi: 10.1186/s11658-024-00638-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.